Time to surgery in early-stage non–small cell lung cancer: Defining the optimal diagnosis-to-resection interval to reduce mortality
Although NSCLC aggressiveness varies, quality metrics for time to surgery are needed to optimize outcomes. This will be increasingly important as more early-stage, resectable NSCLC cases are identified. Our results suggest that performing surgery within 8 weeks of CT-based clinical diagnosis may be an important health system target for early-stage NSCLC patients.
Authors
- Ashish Patel (ORCID: https://orcid.org/0000-0002-5385-3897)
- Diana S. Hsu (ORCID: https://orcid.org/0000-0002-8215-856X)
- Simon Ashiku
- Kian C. Banks (ORCID: https://orcid.org/0000-0001-9623-8627)
- Lori C. Sakoda (ORCID: https://orcid.org/0000-0002-0900-5735)
- Haley I Tupper
- Varada Sarovar (ORCID: https://orcid.org/0009-0005-1860-5133)
- Julie A. Schmittdiel (ORCID: https://orcid.org/0000-0001-8995-5345)
- Jeffrey B. Velotta
Institutions
- San Francisco General Hospital (US)
- Kaiser Permanente (US)
- University of California, Los Angeles (US)
- California State University, East Bay (US)
- Kaiser Permanente San Francisco Medical Center (US)
Publication Details
- Journal
- Journal of Thoracic and Cardiovascular Surgery
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1016/j.jtcvs.2024.11.040
- Citations
- 17
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.12